BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38683607)

  • 1. Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients.
    Daher D; Seif El Dahan K; Rich NE; Tayob N; Merrill V; Huang DQ; Yang JD; Kulkarni AV; Kanwal F; Marrero J; Parikh N; Singal AG
    JAMA Netw Open; 2024 Apr; 7(4):e248755. PubMed ID: 38683607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Survival of Hepatocellular Carcinoma Patients Diagnosed with a Dedicated Screening Programme-a Propensity Score Adjusted Analysis.
    Chinnaratha MA; Campbell K; Mathias R; McCormick RJ; Woodman RJ; Wigg AJ
    J Gastrointest Cancer; 2019 Dec; 50(4):888-893. PubMed ID: 30345486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US.
    Singal AG; Mittal S; Yerokun OA; Ahn C; Marrero JA; Yopp AC; Parikh ND; Scaglione SJ
    Am J Med; 2017 Sep; 130(9):1099-1106.e1. PubMed ID: 28213044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis.
    Moon AM; Weiss NS; Beste LA; Su F; Ho SB; Jin GY; Lowy E; Berry K; Ioannou GN
    Gastroenterology; 2018 Oct; 155(4):1128-1139.e6. PubMed ID: 29981779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis.
    Choi DT; Kum HC; Park S; Ohsfeldt RL; Shen Y; Parikh ND; Singal AG
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):976-987.e4. PubMed ID: 30616961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening.
    Tseng PL; Wang JH; Tung HD; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen PF; Tsai LS; Lu SN
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1426-34. PubMed ID: 20659234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
    Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma.
    Rich NE; Murphy CC; Yopp AC; Tiro J; Marrero JA; Singal AG
    Aliment Pharmacol Ther; 2020 Aug; 52(4):701-709. PubMed ID: 32598091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
    Singal AG; Zhang E; Narasimman M; Rich NE; Waljee AK; Hoshida Y; Yang JD; Reig M; Cabibbo G; Nahon P; Parikh ND; Marrero JA
    J Hepatol; 2022 Jul; 77(1):128-139. PubMed ID: 35139400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.
    Wong CR; Garcia RT; Trinh HN; Lam KD; Ha NB; Nguyen HA; Nguyen KK; Levitt BS; Nguyen MH
    Dig Dis Sci; 2009 Dec; 54(12):2712-21. PubMed ID: 19876735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis.
    Daher D; Seif El Dahan K; Cano A; Gonzales M; Ransom C; Jaurez E; Carranza O; Quirk L; Morgan T; Gopal P; Patel MS; Lieber S; Louissaint J; Cotter TG; VanWagner LB; Yang JD; Parikh ND; Yopp A; Rich NE; Singal AG
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):295-304.e2. PubMed ID: 37573986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening is associated with a lower risk of hepatocellular carcinoma-related mortality in patients with chronic hepatitis B.
    Su F; Weiss NS; Beste LA; Moon AM; Jin GY; Green P; Berry K; Ioannou GN
    J Hepatol; 2021 Apr; 74(4):850-859. PubMed ID: 33245934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
    Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
    J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance.
    Khalaf N; Ying J; Mittal S; Temple S; Kanwal F; Davila J; El-Serag HB
    Clin Gastroenterol Hepatol; 2017 Feb; 15(2):273-281.e1. PubMed ID: 27521507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
    Worland T; Harrison B; Delmenico L; Dowling D
    J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.
    Tayob N; Richardson P; White DL; Yu X; Davila JA; Kanwal F; Feng Z; El-Serag HB
    BMC Med Res Methodol; 2018 Jan; 18(1):1. PubMed ID: 29301497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.
    Atiq O; Tiro J; Yopp AC; Muffler A; Marrero JA; Parikh ND; Murphy C; McCallister K; Singal AG
    Hepatology; 2017 Apr; 65(4):1196-1205. PubMed ID: 27775821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
    Tzartzeva K; Obi J; Rich NE; Parikh ND; Marrero JA; Yopp A; Waljee AK; Singal AG
    Gastroenterology; 2018 May; 154(6):1706-1718.e1. PubMed ID: 29425931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
    Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
    Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: A United States cohort.
    Mittal S; Kanwal F; Ying J; Chung R; Sada YH; Temple S; Davila JA; El-Serag HB
    J Hepatol; 2016 Dec; 65(6):1148-1154. PubMed ID: 27476765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.